Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
First-line avelumab for patients with PD-L1-positive metastatic or locally advanced urothelial cancer who are unfit for cisplatin.
Iacovelli R, Ciccarese C, Brunelli M, Battelli N, Buttigliero C, Caserta C, Buti S, Santini D, Carella C, Galli L, Verri E, Ermacora P, Merler S, Masini C, De Vivo R, Milesi L, Spina F, Rizzo M, Sperduti I, Fornarini G, Tortora G. Iacovelli R, et al. Among authors: verri e. Ann Oncol. 2022 Nov;33(11):1179-1185. doi: 10.1016/j.annonc.2022.07.011. Epub 2022 Aug 2. Ann Oncol. 2022. PMID: 35926813 Free article. Clinical Trial.
Bisphosphonates and jaw osteonecrosis in patients with advanced breast cancer.
Sanna G, Preda L, Bruschini R, Cossu Rocca M, Ferretti S, Adamoli L, Verri E, Franceschelli L, Goldhirsch A, Nolè F. Sanna G, et al. Among authors: verri e. Ann Oncol. 2006 Oct;17(10):1512-6. doi: 10.1093/annonc/mdl163. Epub 2006 Aug 25. Ann Oncol. 2006. PMID: 16936182 Free article.
Sunitinib 2 weeks on, 1 off: strengths and weaknesses.
Iacovelli R, Verri E, Cossu Rocca M, Aurilio G, Cullurà D, Nolé F. Iacovelli R, et al. Among authors: verri e. Ann Oncol. 2015 Jul;26(7):1511-2. doi: 10.1093/annonc/mdv167. Epub 2015 Apr 6. Ann Oncol. 2015. PMID: 25846552 Free article. No abstract available.
Inside the 2015 ASCO Genitourinary Cancers Symposium.
Santoni M, Massari F, Iacovelli R, Ciccarese C, Verri E, Burattini L, Montironi R, Nolè F, Tortora G, Cascinu S. Santoni M, et al. Among authors: verri e. Future Oncol. 2015;11(13):1859-62. doi: 10.2217/fon.15.103. Future Oncol. 2015. PMID: 26161923 Free article.
Is there still a role for sorafenib in metastatic renal cell carcinoma? A systematic review and meta-analysis of the effectiveness of sorafenib over other targeted agents.
Iacovelli R, Verri E, Cossu Rocca M, Aurilio G, Cullurà D, Santoni M, de Cobelli O, Nolé F. Iacovelli R, et al. Among authors: verri e. Crit Rev Oncol Hematol. 2016 Mar;99:324-31. doi: 10.1016/j.critrevonc.2016.01.014. Epub 2016 Jan 19. Crit Rev Oncol Hematol. 2016. PMID: 26818051 Review.
First-Line PAzopanib in NOn-clear-cell Renal cArcinoMA: The Italian Retrospective Multicenter PANORAMA Study.
Buti S, Bersanelli M, Maines F, Facchini G, Gelsomino F, Zustovich F, Santoni M, Verri E, De Giorgi U, Masini C, Morelli F, Vitale MG, Sava T, Prati G, Librici C, Fraccon AP, Fornarini G, Maruzzo M, Leonardi F, Caffo O. Buti S, et al. Among authors: verri e. Clin Genitourin Cancer. 2017 Aug;15(4):e609-e614. doi: 10.1016/j.clgc.2016.12.024. Epub 2016 Dec 29. Clin Genitourin Cancer. 2017. PMID: 28108284
88 results